As of 2025-04-22, the Intrinsic Value of Organon & Co (OGN) is 68.11 USD. This OGN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 10.63 USD, the upside of Organon & Co is 540.70%.
The range of the Intrinsic Value is 46.77 - 107.18 USD
Based on its market price of 10.63 USD and our intrinsic valuation, Organon & Co (OGN) is undervalued by 540.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 46.77 - 107.18 | 68.11 | 540.7% |
| DCF (Growth 10y) | 54.68 - 117.02 | 76.79 | 622.4% |
| DCF (EBITDA 5y) | 29.29 - 50.55 | 35.80 | 236.8% |
| DCF (EBITDA 10y) | 40.33 - 65.69 | 48.88 | 359.8% |
| Fair Value | 16.75 - 16.75 | 16.75 | 57.55% |
| P/E | 38.88 - 60.76 | 50.00 | 370.4% |
| EV/EBITDA | 24.96 - 68.93 | 37.44 | 252.2% |
| EPV | 38.91 - 69.01 | 53.96 | 407.6% |
| DDM - Stable | 21.60 - 43.40 | 32.50 | 205.7% |
| DDM - Multi | 20.10 - 31.65 | 24.60 | 131.4% |
| Market Cap (mil) | 2,742.01 |
| Beta | 0.21 |
| Outstanding shares (mil) | 257.95 |
| Enterprise Value (mil) | 10,947.01 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.40% |
| Cost of Debt | 5.04% |
| WACC | 5.45% |